Status:
COMPLETED
Absorption, Distribution, Metabolism And Excretion Study For GSK221149A
Lead Sponsor:
GlaxoSmithKline
Conditions:
Obstetric Labour, Premature
Premature Labor
Eligibility:
FEMALE
30-55 years
Phase:
PHASE1
Brief Summary
This is a phase one study investigating the absorption, distribution, metabolism and excretion of GSK221149A in six healthy women of non-child bearing potential.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Healthy adult, non-smoking females
- Aged between 30 - 55 years old, and BMI of between 19 and 32
- Not of child-bearing potential
- Exclusion criteria:
- No clinically significant findings on clinical examination, medical examination and blood tests.
- Radiation exposure over previous 3 years is greater than 10mSv
- History of bleeding or gastric problems
Exclusion
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00457925
Start Date
October 1 2006
Last Update
March 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Madison, Wisconsin, United States, 53704